WO2007031883A3 - Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof - Google Patents

Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof Download PDF

Info

Publication number
WO2007031883A3
WO2007031883A3 PCT/IB2006/003852 IB2006003852W WO2007031883A3 WO 2007031883 A3 WO2007031883 A3 WO 2007031883A3 IB 2006003852 W IB2006003852 W IB 2006003852W WO 2007031883 A3 WO2007031883 A3 WO 2007031883A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
acid derivative
naphthoic acid
derivatives
compound
Prior art date
Application number
PCT/IB2006/003852
Other languages
French (fr)
Other versions
WO2007031883A2 (en
Inventor
Claire Mallard
Eve Ferrara
Original Assignee
Galderma Res & Dev
Claire Mallard
Eve Ferrara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0509493A external-priority patent/FR2890861B1/en
Priority to JP2008530661A priority Critical patent/JP5074401B2/en
Priority to MX2008003422A priority patent/MX2008003422A/en
Priority to AU2006290364A priority patent/AU2006290364B2/en
Priority to CA002622468A priority patent/CA2622468A1/en
Priority to KR1020087006011A priority patent/KR101358490B1/en
Application filed by Galderma Res & Dev, Claire Mallard, Eve Ferrara filed Critical Galderma Res & Dev
Priority to EP06831837A priority patent/EP1933827A2/en
Priority to BRPI0617045A priority patent/BRPI0617045B8/en
Publication of WO2007031883A2 publication Critical patent/WO2007031883A2/en
Publication of WO2007031883A3 publication Critical patent/WO2007031883A3/en
Priority to US12/076,169 priority patent/US7998467B2/en
Priority to US13/171,872 priority patent/US8435502B2/en
Priority to US13/889,163 priority patent/US8709392B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Abstract

The invention relates to a composition for topical application comprising, in a physiologically acceptable medium, at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof . The invention is characterized in that the said naphthoic acid derivative is in a form dispersed in the said composition. The invention applies in particular to human pharmacy or cosmetics.
PCT/IB2006/003852 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof WO2007031883A2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
BRPI0617045A BRPI0617045B8 (en) 2005-09-16 2006-09-15 composition, process for preparing a composition, use of a composition and cosmetic use of a composition
MX2008003422A MX2008003422A (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof.
AU2006290364A AU2006290364B2 (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof
CA002622468A CA2622468A1 (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof
KR1020087006011A KR101358490B1 (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof
JP2008530661A JP5074401B2 (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one polyurethane polymer type compound or derivative thereof, process for its preparation and use thereof
EP06831837A EP1933827A2 (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof
US12/076,169 US7998467B2 (en) 2005-09-16 2008-03-14 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
US13/171,872 US8435502B2 (en) 2005-09-16 2011-06-29 Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers
US13/889,163 US8709392B2 (en) 2005-09-16 2013-05-07 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0509493A FR2890861B1 (en) 2005-09-16 2005-09-16 COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOTIC ACID DERIVATIVE AND AT LEAST ONE POLYURETHANE POLYMER TYPE COMPOUND OR DERIVATIVES THEREOF, PROCESS FOR PREPARING THE SAME, AND USE THEREOF
FR0509493 2005-09-16
US72527905P 2005-10-12 2005-10-12
US60/725,279 2005-10-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/076,169 Continuation US7998467B2 (en) 2005-09-16 2008-03-14 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers

Publications (2)

Publication Number Publication Date
WO2007031883A2 WO2007031883A2 (en) 2007-03-22
WO2007031883A3 true WO2007031883A3 (en) 2007-09-13

Family

ID=37865321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/003852 WO2007031883A2 (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof

Country Status (7)

Country Link
EP (1) EP1933827A2 (en)
JP (2) JP5074401B2 (en)
AU (1) AU2006290364B2 (en)
CA (1) CA2622468A1 (en)
MX (1) MX2008003422A (en)
RU (1) RU2421216C2 (en)
WO (1) WO2007031883A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936800B2 (en) 2001-12-21 2015-01-20 Galderma Research & Development Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916975B1 (en) * 2007-06-11 2009-09-04 Galderma Res & Dev COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE, AND USES THEREOF
FR2916966B1 (en) * 2007-06-11 2011-01-14 Galderma Res & Dev COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE, AND USES THEREOF
CA2693061A1 (en) 2007-07-06 2009-01-15 Galderma Research & Development Compositions for topical application for the treatment of keratinization disorders
EP2065032A1 (en) * 2007-11-27 2009-06-03 Galderma Research & Development A method for producing adapalene gels
AU2008337395B2 (en) * 2007-11-30 2014-09-11 Galderma Research & Development Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent
CN102481275B (en) 2009-06-24 2014-07-23 战略科学技术有限公司 Topical composition containing ibuprofen
US9463158B2 (en) 2009-06-24 2016-10-11 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
JP5521190B2 (en) * 2009-10-01 2014-06-11 国立大学法人東京工業大学 Collagen composition and method for producing the same
EP2563357B1 (en) * 2010-04-29 2018-10-17 Galderma Research & Development Adapalene 0.3% for use in a method for treating scars
WO2013131969A2 (en) * 2012-03-09 2013-09-12 Bayer Materialscience Llc Effect of the polyurethane film former on the efficacy of acne treatment

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299758A2 (en) * 1987-07-16 1989-01-18 The Regents Of The University Of California Compositions for enhancing the cutaneous penetration of pharmacologically active agents
JPH061851A (en) * 1992-06-19 1994-01-11 Toyo Ink Mfg Co Ltd Pigment composition and aqueous pigment dispersion
US6358541B1 (en) * 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
WO2003075908A1 (en) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299758A2 (en) * 1987-07-16 1989-01-18 The Regents Of The University Of California Compositions for enhancing the cutaneous penetration of pharmacologically active agents
JPH061851A (en) * 1992-06-19 1994-01-11 Toyo Ink Mfg Co Ltd Pigment composition and aqueous pigment dispersion
US6358541B1 (en) * 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
US20020155180A1 (en) * 2000-05-03 2002-10-24 Goodman David S. Topical preparation for treating acne and hirsutism
WO2003075908A1 (en) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199406, Derwent World Patents Index; Class A60, AN 1994-045515, XP002261340 *
KANG SEWON ET AL: "Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial.", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. JUL 2003, vol. 49, no. 1, July 2003 (2003-07-01), pages 83 - 90, XP002376857, ISSN: 0190-9622 *
WOLF J E: "An update of recent clinical trials examining adapalene and acne", JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2001 UNITED KINGDOM, vol. 15, no. SUPPL. 3, 2001, pages 23 - 29, XP002382359, ISSN: 0926-9959 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936800B2 (en) 2001-12-21 2015-01-20 Galderma Research & Development Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

Also Published As

Publication number Publication date
JP2009508843A (en) 2009-03-05
WO2007031883A2 (en) 2007-03-22
EP1933827A2 (en) 2008-06-25
RU2421216C2 (en) 2011-06-20
CA2622468A1 (en) 2007-03-22
RU2008114840A (en) 2009-10-27
AU2006290364A1 (en) 2007-03-22
MX2008003422A (en) 2008-03-27
JP5074401B2 (en) 2012-11-14
AU2006290364B2 (en) 2012-07-05
JP2012184258A (en) 2012-09-27

Similar Documents

Publication Publication Date Title
WO2007031883A3 (en) Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof
WO2009077693A3 (en) Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent
WO2006099941A8 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
WO2009074735A8 (en) Use of a novel natural agent in cosmetic compositions
WO2010072958A3 (en) Topical pharmaceutical composition containing a water-sensitive active principle
WO2008139122A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
WO2007129270A3 (en) Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle
WO2008034764A3 (en) Cosmetic preparations based on molecularly imprinted polymers
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
MX2009005308A (en) Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use.
WO2008015249A3 (en) Cosmetic or pharmaceutical composition containing hyaluronic acid
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
IL188494A0 (en) Novel 2,4-dianlinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
WO2007132134A3 (en) Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof
WO2007078857A3 (en) Use of non-straight fibers dispersed in a composition and compositions thereof
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
WO2006042661A3 (en) Oligopeptides and their use in cosmetics
WO2011039444A3 (en) Composition, use, and preservation method
IL201730A (en) Derivatives of 1h-benzoimidazol-2-yl-propyl-methyl-amino-ethyl-5-aryl-bicyclo[2.2.2]oct-5-en-2-ol, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
WO2008139123A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
WO2007075255A3 (en) Mastic gum composition for use as a dietary supplement in humans and animals
BRPI0617045B8 (en) composition, process for preparing a composition, use of a composition and cosmetic use of a composition
WO2007077318A3 (en) Use of a peptidic rice extract as an active agent inducing the synthesis of sirt proteins in skin cells
PL1868631T3 (en) Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition
WO2008148966A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, methods for the preparation thereof, and uses thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2006831837

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006290364

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/003422

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1020087006011

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2622468

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008530661

Country of ref document: JP

Ref document number: 200680033965.4

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2239/DELNP/2008

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2006290364

Country of ref document: AU

Date of ref document: 20060915

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006290364

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2008114840

Country of ref document: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06831837

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 2006831837

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0617045

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080314